-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-protocol.pdf
July 10, 2018 - sertraline or trazadone or trimipramine or venlafaxine or vilazodone or vortioxetine).ti,ab.
24. exp Amphetamines
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-267-adhd-executive-summary.pdf
March 01, 2024 - Executive Summary: ADHD Diagnosis and Treatment in Children and Adolescents
Comparative Effectiveness Review
Number 267
ADHD Diagnosis and Treatment in
Children and Adolescents
Executive Summary
Main Points
Diagnosis
• Multiple approaches showed promising diagnostic performance (e.g., usin…
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-4.pdf
January 01, 2011 - Accurate ADHD Diagnosis, Measure 1, Section 5, Attachment 4
SNAC Submission Form Measure 1: Accurate ADHD Diagnosis
Section 5: Evidence
Attachment 4: ADHD Guidelines Review
Aspect of Care Devel…
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-4.pdf
January 01, 2011 - ADHD Guidelines Review
SNAC Submission Form ADHD Measure 2: Behavior Therapy
Section 5: Evidence
Attachment 4: ADHD Guidelines Review
Aspect of Care Developer Guideline Recommendations …
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-4.pdf
January 01, 2011 - ADHD Guidelines Review
SNAC Submission Form ADHD Measure 2: Behavior Therapy
Section 5: Evidence
Attachment 4: ADHD Guidelines Review
Aspect of Care Developer Guideline Recommendations …
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-4.pdf
January 01, 2011 - Accurate ADHD Diagnosis, Measure 1, Section 5, Attachment 4
SNAC Submission Form Measure 1: Accurate ADHD Diagnosis
Section 5: Evidence
Attachment 4: ADHD Guidelines Review
Aspect of Care Devel…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-4.pdf
January 01, 2011 - ADHD Guidelines Review
SNAC Submission Form ADHD Measure 2: Behavior Therapy
Section 5: Evidence
Attachment 4: ADHD Guidelines Review
Aspect of Care Developer Guideline Recommendations …
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-4.pdf
January 01, 2011 - Accurate ADHD Diagnosis, Measure 1, Section 5, Attachment 4
SNAC Submission Form Measure 1: Accurate ADHD Diagnosis
Section 5: Evidence
Attachment 4: ADHD Guidelines Review
Aspect of Care Devel…
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-4.pdf
January 01, 2011 - Accurate ADHD Diagnosis, Measure 1, Section 5, Attachment 4
SNAC Submission Form Measure 1: Accurate ADHD Diagnosis
Section 5: Evidence
Attachment 4: ADHD Guidelines Review
Aspect of Care Devel…
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-4.pdf
January 01, 2011 - ADHD Guidelines Review
SNAC Submission Form ADHD Measure 2: Behavior Therapy
Section 5: Evidence
Attachment 4: ADHD Guidelines Review
Aspect of Care Developer Guideline Recommendations …
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-4.pdf
January 01, 2011 - ADHD Guidelines Review
SNAC Submission Form ADHD Measure 2: Behavior Therapy
Section 5: Evidence
Attachment 4: ADHD Guidelines Review
Aspect of Care Developer Guideline Recommendations …
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-4.pdf
January 01, 2011 - ADHD Guidelines Review
SNAC Submission Form ADHD Measure 2: Behavior Therapy
Section 5: Evidence
Attachment 4: ADHD Guidelines Review
Aspect of Care Developer Guideline Recommendations …
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-4.pdf
January 01, 2011 - Accurate ADHD Diagnosis, Measure 1, Section 5, Attachment 4
SNAC Submission Form Measure 1: Accurate ADHD Diagnosis
Section 5: Evidence
Attachment 4: ADHD Guidelines Review
Aspect of Care Devel…
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-4.pdf
January 01, 2011 - Accurate ADHD Diagnosis, Measure 1, Section 5, Attachment 4
SNAC Submission Form Measure 1: Accurate ADHD Diagnosis
Section 5: Evidence
Attachment 4: ADHD Guidelines Review
Aspect of Care Devel…
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-4.pdf
January 01, 2011 - ADHD Guidelines Review
SNAC Submission Form ADHD Measure 2: Behavior Therapy
Section 5: Evidence
Attachment 4: ADHD Guidelines Review
Aspect of Care Developer Guideline Recommendations …
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-4.pdf
January 01, 2011 - Accurate ADHD Diagnosis, Measure 1, Section 5, Attachment 4
SNAC Submission Form Measure 1: Accurate ADHD Diagnosis
Section 5: Evidence
Attachment 4: ADHD Guidelines Review
Aspect of Care Devel…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/binge-eating_clinician.pdf
May 01, 2016 - . (���)
The FDA lists the following warnings:
�� CNS stimulants (amphetamines and methylphenidate-containing
-
effectivehealthcare.ahrq.gov/products/binge-eating/clinician
May 24, 2016 - evidence low]
FDA Medication Warnings
The FDA lists the following warnings:
CNS stimulants (amphetamines
-
hcup-us.ahrq.gov/reports/statbriefs/sb109.jsp
April 01, 2011 - antibiotics)‡
88,000
4.1%
45,800
4.6%
8
4
Psychotropic agents (other than hallucinogens, amphetamines … 960.3, 960.8, 960.9, E856, E930.3, E930.8, E930.9
Psychotropic agents (other than hallucinogens, amphetamines
-
psnet.ahrq.gov/web-mm/complications-vascular-access-procedures-patients-kidney-disease
May 26, 2021 - Her toxicology report in the hospital emergency department was positive for amphetamines, opiates and